Table 2:

Comorbidities of participantsa

Study GroupNPHHC-MHC-Y
Arterial hypertension5/106/180/14
Arteriovenous malformation0/100/182/14
Atrial fibrillation0/102/180/14
Headaches0/101/181/14
Coronary heart disease2/100/180/14
Dizziness1/100/180/14
Meningiomab0/101/180/14
Microangiopathy1/101/180/14
Multiple sclerosis0/100/184/14
Orthostatic tremor1/100/180/14
Peripheral arterial disease1/100/180/14
Restless leg syndrome0/101/180/14
Seizure disorder1/100/181/14
Prior stroke1/103/180/14
History of syncope0/101/180/14
History of transient ischemic attack0/102/180/14
  • a Data are number of patients per study group.

  • b The meningioma measured 1.2 cm at the maximum.